(3) The Part B IPI Model The Certara Market Access Channel
-
- Science
In this episode, we're dissecting the US Administrations initiative to overhaul Medicare Part B drug reimbursement, incorporating international reference pricing.
Experts on call
Ulrich Neumann, Sr. Director, US Access ulrich.neumann@certara.com
Additional notes:
- We referenced the Implications of Pricing on Innovation which is thoroughly discussed in this article by USC's Darius Lakdawalla
Lakdawalla, Darius N. 2018. "Economics of the Pharmaceutical Industry." Journal of Economic Literature, 56 (2): 397-449.
DOI: 10.1257/jel.20161327
---
Send in a voice message: https://podcasters.spotify.com/pod/show/market-access/message
In this episode, we're dissecting the US Administrations initiative to overhaul Medicare Part B drug reimbursement, incorporating international reference pricing.
Experts on call
Ulrich Neumann, Sr. Director, US Access ulrich.neumann@certara.com
Additional notes:
- We referenced the Implications of Pricing on Innovation which is thoroughly discussed in this article by USC's Darius Lakdawalla
Lakdawalla, Darius N. 2018. "Economics of the Pharmaceutical Industry." Journal of Economic Literature, 56 (2): 397-449.
DOI: 10.1257/jel.20161327
---
Send in a voice message: https://podcasters.spotify.com/pod/show/market-access/message
26 min